Tau filaments from multiple cases of sporadic and inherited Alzheimer's disease adopt a common fold.

Benjamin Falcon, Wenjuan Zhang, Manuel Schweighauser, Alexey G. Murzin, Rubén Vidal, Holly J. Garringer, Bernardino Ghetti, Sjors H. W. Scheres, Michel Goedert

TL;DR

This study reveals that tau filaments, a hallmark of Alzheimer's disease (AD), share a remarkably consistent structure across diverse AD cases, including both sporadic and inherited forms. This finding is crucial for developing targeted therapies and diagnostics by providing a unified understanding of the molecular basis of tau pathology.

What Problem Does This Paper Address?

Alzheimer's disease (AD) is characterized by the abnormal accumulation of tau protein into neurofibrillary tangles. These tau filaments exist in different forms, primarily paired helical filaments (PHFs) and straight filaments (SFs). A key question in the field has been whether the precise structure of these tau filaments varies between individuals with AD, particularly between sporadic (most common) and inherited forms, or even between different brain regions within an individual. Understanding this structural variability is critical for developing effective treatments that target the specific molecular mechanisms of tau aggregation and propagation. Previous high-resolution structural studies had been limited to a single case of AD, leaving the broader structural landscape of tau filaments in AD largely unexplored.

Methods

The researchers employed a powerful combination of electron cryo-microscopy (cryo-EM) and immuno-gold negative-stain electron microscopy (immuno-EM).

  • Cryo-EM: This technique allows for the determination of high-resolution 3D structures of biological molecules, including protein filaments. The authors used cryo-EM to resolve the detailed atomic structures of PHFs and SFs from the frontal cortex of several AD cases. They utilized advanced image processing techniques, including helical reconstruction algorithms in RELION, to achieve resolutions down to ~3.2 Å. This allowed them to identify the specific amino acid residues that form the core of the filaments.
  • Immuno-EM: This method uses antibodies tagged with gold particles to visualize and localize specific proteins or protein regions within the filaments. By using antibodies that recognize different parts of the tau protein, the researchers could map which tau sequences were exposed on the filament surface (the "fuzzy coat") versus those buried within the core. They also used pronase treatment to selectively degrade the fuzzy coat, allowing them to confirm which regions were truly part of the filament core.

This dual approach allowed them to combine high-resolution structural insights with broader surveys across multiple cases and brain regions.

Datasets

The study analyzed tau filaments extracted from the frontal cortex of 17 cases of AD (15 sporadic and 2 inherited). For high-resolution cryo-EM, detailed structural analysis was performed on samples from 3 cases of AD (2 sporadic and 1 inherited). Immuno-EM was used to analyze filaments from these cases, as well as from an additional 12 cases of sporadic AD and 1 case of inherited AD. Furthermore, tau filaments from various brain regions (temporal, occipital, parietal, and cingulate cortices, as well as thalamus, substantia innominata, and putamen) of one sporadic AD case were examined. Two cases of atypical AD (posterior cortical atrophy) were also included.

Key Insights and Ideas

  • Unified Tau Fold: The most striking finding is that tau filaments from diverse AD cases (sporadic, inherited, typical, and atypical) adopt a common, conserved fold. This suggests that the fundamental mechanism of tau filament assembly is remarkably similar across different genetic backgrounds and clinical presentations of AD.
  • Core Structure Defined: The high-resolution cryo-EM structures revealed that the core of both PHFs and SFs is formed by two C-shaped protofilaments, adopting a cross-β/β-helix structure. This core is primarily composed of tau residues from repeats R3 and R4, along with specific amino acids flanking these repeats.
  • Fuzzy Coat vs. Core: Immuno-EM experiments clearly delineated the filament core from the outer "fuzzy coat." Antibodies targeting tau residues within repeats R3 and R4 strongly labeled the filament core, even after pronase treatment removed the fuzzy coat. Conversely, antibodies targeting regions within R1 and R2 were only effective before pronase treatment, indicating these regions form the fuzzy coat.
  • Implications for Therapy: The identification of a common structural core has profound implications for therapeutic development. It suggests that drugs or antibodies designed to target this conserved core structure could be broadly effective across a wide range of AD patients, rather than needing to be tailored to specific structural variants.
  • Diagnostic Potential: Similarly, diagnostic tools that can detect or bind to this common core structure could offer more reliable and universal detection of AD pathology.

Key Results

  • High-Resolution Structures: Cryo-EM determined the structures of PHFs and SFs from AD cases to resolutions of ~3.2 Å and ~3.3 Å, respectively.
  • Common Protofilament Fold: The structures revealed that PHFs and SFs are composed of two C-shaped protofilaments with a shared cross-β/β-helix architecture.
  • Conserved Core Sequence: Immuno-EM confirmed that the core of tau filaments across all 17 sporadic and 2 inherited AD cases studied consistently contained tau residues from repeats R3 and R4.
  • No Significant Variation: The study found no significant structural variation in tau filaments between individuals with AD, regardless of whether the disease was sporadic or inherited, or which brain region was examined.

Limitations and Future Work

  • Low Throughput of Cryo-EM: The authors acknowledge that cryo-EM is a low-throughput technique, which is why immuno-EM was crucial for surveying a larger number of cases and brain regions.
  • Starting Point of Assembly: The study focuses on the structures of filaments found in end-stage AD. The authors note that these structures do not fully explain how the assembly process begins, suggesting that cofactors like heparin or chemical modifications might be involved in the initial ordered assembly of tau.
  • Comparison to Other Tauopathies: While distinct tau filament folds are known in other tauopathies (e.g., Pick's disease), the paper raises the question of whether the common fold observed in AD is unique to this disease or if other tauopathies also exhibit conserved structures within their respective disease types. Future work could involve similar high-resolution structural studies of tau filaments from a wider range of tauopathies to explore this.
  • Role of Extra Densities: The higher resolution structures revealed additional densities at the N- and C-termini of the protofilament core. The paper speculates that these might correspond to water molecules or post-translational modifications, and their precise role in filament stabilization or interaction warrants further investigation.

Summary updated

Abstract

Abstract The ordered assembly of tau protein into abnormal filaments is a defining characteristic of Alzheimer’s disease (AD) and other neurodegenerative disorders. It is not known if the structures of tau filaments vary within, or between, the brains of individuals with AD. We used a combination of electron cryo-microscopy (cryo-EM) and immuno-gold negative-stain electron microscopy (immuno-EM) to determine the structures of paired helical filaments (PHFs) and straight filaments (SFs) from the frontal cortex of 17 cases of typical AD (15 sporadic and 2 inherited) and 2 cases of atypical AD (posterior cortical atrophy). The high-resolution structures of PHFs and SFs from the frontal cortex of 3 cases of typical AD, 2 sporadic and 1 inherited, were determined by cryo-EM. We also used immuno-EM to study the PHFs and SFs from a number of cortical and subcortical brain regions. PHFs outnumbered SFs in all AD cases. By cryo-EM, PHFs and SFs were made of two C-shaped protofilaments with a combined cross-β/β-helix structure, as described previously for a case of AD. The higher resolution structures obtained here showed two additional amino acids at each end of the protofilament structure. The immuno-EM findings, which established the presence of repeats 3 and 4, but not repeats 1 and 2, of tau in the filament cores of all AD cases and brain regions thereof, were consistent with the cryo-EM results. These findings show that there is no significant variation in tau filament structures between individuals with AD. This knowledge will be crucial for understanding the mechanisms that underlie tau filament formation and for developing novel diagnostics and therapies.
BibTeX
@inproceedings{falcon2018tau,
  author = {Benjamin Falcon and Wenjuan Zhang and Manuel Schweighauser and Alexey G. Murzin and Rubén Vidal and Holly J. Garringer and Bernardino Ghetti and Sjors H. W. Scheres and Michel Goedert},
  title = {{Tau filaments from multiple cases of sporadic and inherited Alzheimer's disease adopt a common fold.}},
  booktitle = {Apollo},
  year = {2018},
  doi = {10.17863/cam.33326},
}
Figure